Cupertino, CA, United States of America

Yu-Ling Cheng


Average Co-Inventor Count = 4.0

ph-index = 7

Forward Citations = 581(Granted Patents)


Company Filing History:


Years Active: 1988-1990

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovator Yu-Ling Cheng: Pioneering Transdermal Drug Delivery

Introduction

Yu-Ling Cheng, an accomplished inventor based in Cupertino, CA, is recognized for her significant contributions in the field of transdermal drug delivery systems. With a portfolio of seven patents, she has made a remarkable impact in enhancing the effectiveness of therapeutic treatments.

Latest Patents

One of her latest patents focuses on "Skin permeation enhancer compositions using sucrose esters." This innovative method aims to enhance the transdermal flux of drugs delivered through intact skin. Her research outlines a system whereby the drug is delivered in conjunction with sucrose monolaurate or a mixture of sucrose esters derived from coconut fatty acids, primarily sucrose monolaurate. The preferred embodiments of her therapeutic systems are designed to employ a matrix that contains the drug at concentrations exceeding saturation, allowing for improved delivery and efficacy.

Career Highlights

Yu-Ling Cheng is currently affiliated with Alza Corporation, a leader in the development of innovative drug delivery technologies. Over her career, she has developed a range of groundbreaking solutions that play a crucial role in modern medicine.

Collaborations

Throughout her career, Yu-Ling has worked alongside esteemed colleagues in the field, including Harold F. Sanders and Robert M. Gale. These collaborations have been instrumental in advancing her research and innovations in drug delivery technologies.

Conclusion

In conclusion, Yu-Ling Cheng stands out as a prominent inventor whose work significantly enhances the field of transdermal drug delivery. Her patents reflect her commitment to innovation and improvement in therapeutic systems, making her a vital contributor to the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…